Major Research Partnership Unveiled By Two Global Health Companies

Avidity Biosciences and Bristol Myers Squibb Team Up in a Groundbreaking $2.3 Billion Cardiovascular Collaboration.

In what is being hailed as a major development in the field of cardiovascular health, Avidity Biosciences Inc announced a global licensing and research collaboration with industry giant Bristol Myers Squibb. This partnership is aimed at the discovery, development, and commercialization of multiple cardiovascular targets, with potential cumulative paymen…